NAMPT and type 2 diabetes mellitus: Patients with type 2 diabetes, women with gestational diabetes, and women with PCOS tend to have higher plasma visfatin concentrations compared with controls, which would confirm its role in the determinism of insulin resistance and thus a potential role in the control of ovarian steroidogenesis.